{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:02:55Z","timestamp":1790463775759,"version":"4.1.0"},"reference-count":205,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009781","name":"Australian Centre for HIV and Hepatitis Virology Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the fourth leading cause of cancer-related death. The most common risk factor for developing HCC is chronic infection with hepatitis B virus (HBV). Early stages of HBV-related HCC (HBV-HCC) are generally asymptomatic. Moreover, while serum alpha-fetoprotein (AFP) and abdominal ultrasound are widely used to screen for HCC, they have poor sensitivity. Thus, HBV-HCC is frequently diagnosed at an advanced stage, in which there are limited treatment options and high mortality rates. Serum biomarkers with high sensitivity and specificity are crucial for earlier diagnosis of HCC and improving survival rates. As viral\u2013host interactions are key determinants of pathogenesis, viral biomarkers may add greater diagnostic power for HCC than host biomarkers alone. In this review, we summarize recent research on using virus-derived biomarkers for predicting HCC occurrence and recurrence; including circulating viral DNA, RNA transcripts, and viral proteins. Combining these viral biomarkers with AFP and abdominal ultrasound could improve sensitivity and specificity of early diagnosis, increasing the survival of patients with HBV-HCC. In the future, as the mechanisms that drive HBV-HCC to become clearer, new biomarkers may be identified which can further improve early diagnosis of HBV-HCC.<\/jats:p>","DOI":"10.3389\/fmicb.2021.665201","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T09:41:46Z","timestamp":1623663706000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Viral Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Occurrence and Recurrence"],"prefix":"10.3389","volume":"12","author":[{"given":"Yuanyuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.hpb.2016.05.005","article-title":"Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study.","volume":"18","author":"Adler","year":"2016","journal-title":"HPB"},{"key":"B2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jiph.2019.08.004","article-title":"Moving towards hepatitis B elimination in Gulf Health Council states: from commitment to action.","volume":"13","author":"Al Awaidy","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00261","article-title":"Host and viral genetic variation in HBV-related hepatocellular carcinoma.","volume":"9","author":"An","year":"2018","journal-title":"Front. Genet."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030949","article-title":"Novel biomarkers of hepatitis B and hepatocellular carcinoma: clinical significance of HBcrAg and M2BPGi.","volume":"21","author":"Baudi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2013.06.018","article-title":"Hepatitis B virus splicing is enhanced prior to development of hepatocellular carcinoma.","volume":"59","author":"Bayliss","year":"2013","journal-title":"J. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jvh.13394","article-title":"Hepatitis B core-related antigen levels predict recurrence-free survival in patients with HBV-associated early-stage hepatocellular carcinoma: results from a Dutch long-term follow-up study.","volume":"28","author":"Beudeker","year":"2021","journal-title":"J. Viral Hepat."},{"key":"B7","doi-asserted-by":"publisher","first-page":"11135","DOI":"10.1073\/pnas.0403925101","article-title":"Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration.","volume":"101","author":"Bill","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/liv.13086","article-title":"New therapies for chronic hepatitis B.","volume":"36","author":"Bitton Alaluf","year":"2016","journal-title":"Liver Int."},{"key":"B9","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2016.02.008","article-title":"Intracellular transport and egress of hepatitis B virus.","volume":"64","author":"Blondot","year":"2016","journal-title":"J. Hepatol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-5-95","article-title":"Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection.","volume":"5","author":"Bolukbas","year":"2005","journal-title":"BMC Infect. Dis."},{"key":"B11","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary liver cancer: worldwide incidence and trends.","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"B13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1749-6632.2001.tb03886.x","article-title":"Hepatitis B virus nucleic acids circulating in the blood: distinct patterns in HBs carriers with hepatocellular carcinoma.","volume":"945","author":"Breitkreutz","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/genes9070365","article-title":"Cellular genomic sites of hepatitis B virus DNA integration.","volume":"9","author":"Budzinska","year":"","journal-title":"Genes"},{"key":"B15","article-title":"Sequence analysis of integrated hepatitis B virus DNA during HBeAg-seroconversion.","volume":"7","author":"Budzinska","year":"","journal-title":"Emerg. Microbes Infect."},{"key":"B16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jcv.2014.05.013","article-title":"Quantification of hepatitis B surface antigen with the novel DiaSorin LIAISON XL Murex HBsAg Quant: correlation with the ARCHITECT quantitative assays.","volume":"60","author":"Burdino","year":"2014","journal-title":"J. Clin. Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/hep.30082","article-title":"Hepatitis B virus serum DNA and RNA levels in nucleos (t) ide analog-treated or untreated patients during chronic and acute infection.","volume":"68","author":"Butler","year":"2018","journal-title":"Hepatol. Int."},{"key":"B18","first-page":"1","article-title":"Biological and clinical significance of hepatitis B virus RNA splicing: an update.","volume":"2","author":"Candotti","year":"2017","journal-title":"Ann. Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/hep.31026","article-title":"Pre-genomic HBV RNA and HBcrAg predict outcomes in HBeAg negative chronic hepatitis B patients suppressed on nucleos (t) ide analogue therapy.","volume":"72","author":"Carey","year":"2019","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.31026","article-title":"Pregenomic HBV RNA and hepatitis B core-related antigen predict outcomes in hepatitis B e antigen-negative chronic hepatitis B patients suppressed on nucleos (t) ide analogue therapy.","volume":"72","author":"Carey","year":"2020","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/hep.510240304","article-title":"Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis.","volume":"24","author":"Carman","year":"1996","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/hep.28394","article-title":"Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.","volume":"63","author":"Cassinotto","year":"2016","journal-title":"Hepatology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3748\/wjg.v24.i14.1507","article-title":"Hepatitis B virus pre-S\/S variants in liver diseases.","volume":"24","author":"Chen","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"B24","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1053\/j.gastro.2011.06.036","article-title":"Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.","volume":"141","author":"Chen","year":"2011","journal-title":"Gastroenterology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1053\/j.gastro.2007.09.002","article-title":"Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.","volume":"133","author":"Chen","year":"2007","journal-title":"Gastroenterology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"B27","article-title":"Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B.","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cca.2018.07.027","article-title":"Clinical evaluation of hepatitis B core-related antigen in chronic hepatitis B and hepatocellular carcinoma patients.","volume":"486","author":"Chen","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"B29","article-title":"Viral integration drives multifocal HCC during the occult HBV infection.","volume":"38","author":"Chen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/apt.13630","article-title":"Clinical outcomes after spontaneous and nucleos (t) ide analogue-treated HB sAg seroclearance in chronic HBV infection.","volume":"43","author":"Chen","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02048","article-title":"HBV-induced immune imbalance in the development of HCC.","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1089\/vim.2016.0162","article-title":"Hepatitis B surface antigen promotes the invasion of hepatitis B virus-related hepatocellular carcinoma cells by Upregulation of toll-like receptor 2.","volume":"30","author":"Cheng","year":"2017","journal-title":"Viral Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/jvh.12688","article-title":"Relationship between HB sAg, HB crAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos (t) ide therapy.","volume":"24","author":"Cheung","year":"2017","journal-title":"J. Viral Hepat."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1128\/jcm.01306-10","article-title":"Performance of version 2.0 of the Cobas AmpliPrep\/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification.","volume":"48","author":"Chevaliez","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1128\/jcm.01248-07","article-title":"Performance of the Cobas AmpliPrep\/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification.","volume":"46","author":"Chevaliez","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1002\/hep.30233","article-title":"Longitudinal assessment of three serum biomarkers to detect very early-stage hepatocellular carcinoma.","volume":"69","author":"Choi","year":"2019","journal-title":"Hepatology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.amjmed.2003.12.040","article-title":"Natural history of hepatitis be antigen to antibody seroconversion in patients with normal serum aminotransferase levels.","volume":"116","author":"Chu","year":"2004","journal-title":"Am. J. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00535-009-0093-z","article-title":"The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma.","volume":"44","author":"Chuma","year":"2009","journal-title":"J. Gastroenterol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jhep.2016.08.009","article-title":"The role of quantitative hepatitis B surface antigen revisited.","volume":"66","author":"Cornberg","year":"2017","journal-title":"J. Hepatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.7326\/0003-4819-118-3-199302010-00006","article-title":"The natural history of asymptomatic hepatitis B surface antigen carriers.","volume":"118","author":"De Franchis","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jviromet.2003.10.002","article-title":"Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay.","volume":"115","author":"Deguchi","year":"2004","journal-title":"J. Virol. Methods"},{"key":"B42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3343\/alm.2012.32.2.113","article-title":"Relationship of oxidative stress in hepatitis B infection activity with HBV DNA and fibrosis.","volume":"32","author":"Duygu","year":"2012","journal-title":"Ann. Lab. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1046\/j.1440-1746.2000.02187.x","article-title":"Identification of a pre-S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection.","volume":"15","author":"Fan","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/jhep.2001.21163","article-title":"Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection.","volume":"33","author":"Fan","year":"2001","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors.","volume":"48","author":"Fattovich","year":"2008","journal-title":"J. Hepatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/00042737-200604000-00015","article-title":"Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations.","volume":"18","author":"Foucher","year":"2006","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2036.2007.03390.x","article-title":"Low serum HBV DNA levels and development of hepatocellular carcinoma in patients with chronic hepatitis B: a case\u2013control study.","volume":"26","author":"Fung","year":"2007","journal-title":"Aliment. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25960","article-title":"Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers.","volume":"9","author":"Furuta","year":"2018","journal-title":"Oncotarget"},{"key":"B50","first-page":"2923","article-title":"Hepadnaviridae: the viruses and their replication","author":"Ganem","year":"2001","journal-title":"Fields Virology"},{"key":"B51","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","article-title":"Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma.","volume":"179","author":"Gao","year":"2019","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1053\/j.gastro.2007.02.039","article-title":"Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B.","volume":"132","author":"Ghany","year":"2007","journal-title":"Gastroenterology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jhep.2016.09.028","article-title":"Serum HBV pgRNA as a clinical marker for cccDNA activity.","volume":"66","author":"Giersch","year":"2017","journal-title":"J. Hepatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s12072-011-9255-1","article-title":"Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation.","volume":"5","author":"Goto","year":"2011","journal-title":"Hepatol. Int."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1038\/sj.bjc.6602590","article-title":"Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients.","volume":"92","author":"Greten","year":"2005","journal-title":"Br. J. Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1006\/viro.1997.8863","article-title":"Heterogeneity and common features of defective hepatitis B virus genomes derived from spliced pregenomic RNA.","volume":"238","author":"G\u00fcnther","year":"1997","journal-title":"Virology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/hep.29463","article-title":"Hepatitis B virus pregenomic RNA in hepatocellular carcinoma: a nosological and prognostic determinant.","volume":"67","author":"Halgand","year":"2018","journal-title":"Hepatology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41423-019-0330-1","article-title":"HBsAg-specific CD8+ T cells as an indispensable trigger to induce murine hepatocellular carcinoma.","volume":"18","author":"Hao","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/hep.20748","article-title":"Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals.","volume":"42","author":"Hass","year":"2005","journal-title":"Hepatol. Int."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/hep.21581","article-title":"Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine.","volume":"45","author":"Hatakeyama","year":"2007","journal-title":"Hepatology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/emboj\/21.4.525","article-title":"The PreS2 activator MHBst of hepatitis B virus activates c-raf-1\/Erk2 signaling in transgenic mice.","volume":"21","author":"Hildt","year":"2002","journal-title":"EMBO J."},{"key":"B62","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1128\/jvi.65.8.4284-4291.1991","article-title":"Diversity of hepatitis B virus X gene-related transcripts in hepatocellular carcinoma: a novel polyadenylation site on viral DNA.","volume":"65","author":"Hilger","year":"1991","journal-title":"J. Virol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/apt.15108","article-title":"Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos (t) ide analogues.","volume":"49","author":"Hosaka","year":"2019","journal-title":"Aliment. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1478-3231.2010.02344.x","article-title":"HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.","volume":"30","author":"Hosaka","year":"2010","journal-title":"Liver Int."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/carcin\/bgh207","article-title":"Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.","volume":"25","author":"Hsieh","year":"2004","journal-title":"Carcinogenesis"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1053\/jhep.2002.33638","article-title":"Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.","volume":"35","author":"Hsu","year":"2002","journal-title":"Hepatology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"245","DOI":"10.21873\/anticanres.13946","article-title":"High rate of detection of human ESPL1-HBV S Fusion Gene in Patients With HBV-related Liver Cancer: a Chinese Case\u2013Control Study.","volume":"40","author":"Hu","year":"2020","journal-title":"Anticancer Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1111\/jgh.14075","article-title":"Integration of hepatitis B virus S gene impacts on hepatitis B surface antigen levels in patients with antiviral therapy.","volume":"33","author":"Hu","year":"2018","journal-title":"J. Gastroenterol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1001\/jamasurg.2013.4648","article-title":"Prediction of hepatocellular carcinoma recurrence in patients with low hepatitis B virus DNA levels and high preoperative hepatitis B surface antigen levels.","volume":"149","author":"Huang","year":"2014","journal-title":"JAMA Surg."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1245\/s10434-012-2803-7","article-title":"Early viral suppression predicts good postoperative survivals in patients with hepatocellular carcinoma with a high baseline HBV-DNA load.","volume":"20","author":"Huang","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jcv.2017.12.016","article-title":"Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naive HBV-infected individuals.","volume":"99","author":"Huang","year":"2018","journal-title":"J. Clin. Virol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1006\/viro.2000.0478","article-title":"Identification and characterization of a structural protein of hepatitis B virus: a polymerase and surface fusion protein encoded by a spliced RNA.","volume":"275","author":"Huang","year":"2000","journal-title":"Virology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/jmv.21117","article-title":"Role of hepatitis B virus genotypes and quantitative HBV DNA in metastasis and recurrence of hepatocellular carcinoma.","volume":"80","author":"Huang","year":"2008","journal-title":"J. Med. Virol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3851\/imp2777","article-title":"On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy.","volume":"20","author":"Huang","year":"2015","journal-title":"Antivir. Ther."},{"key":"B75","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3350\/cmh.2020.0115","article-title":"Persistence of intrahepatic HBV DNA integration in patients developing hepatocellular carcinoma after HBsAg seroclearance.","volume":"27","author":"Jang","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"B77","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2013.56","article-title":"Hepatitis B virus reverse transcriptase: diverse functions as classical and emerging targets for antiviral intervention.","volume":"2","author":"Jones","year":"2013","journal-title":"Emerg. Microbes Infect."},{"key":"B78","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/hep.24121","article-title":"Risk assessment of hepatitis B virus\u2013related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).","volume":"53","author":"Jung","year":"2011","journal-title":"Hepatology"},{"key":"B79","first-page":"94","article-title":"PO-021: role of HBsAg Titer and HBV DNA Level in Predicting Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Entecavir Therapy.","volume":"2017","author":"Kang","year":"2017","journal-title":"Korean J. Hepatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00535-015-1126-4","article-title":"Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.","volume":"51","author":"Kawai-Kitahata","year":"2016","journal-title":"J. Gastroenterol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000343857","article-title":"Quantitative levels of hepatitis B virus DNA and surface antigen and the risk of hepatocellular carcinoma in patients with hepatitis B receiving long-term nucleos (t) ide analogue therapy.","volume":"3","author":"Kawanaka","year":"2014","journal-title":"Liver Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.patbio.2010.01.005","article-title":"Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.","volume":"58","author":"Kew","year":"2010","journal-title":"Pathol. Biol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1478-3231.2007.01625.x","article-title":"Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection.","volume":"28","author":"Kim","year":"2008","journal-title":"Liver Int."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jhep.2014.11.031","article-title":"Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.","volume":"62","author":"Kim","year":"2015","journal-title":"J. Hepatol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/hep.28916","article-title":"Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment.","volume":"66","author":"Kim","year":"2017","journal-title":"Hepatology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1128\/jcm.40.2.439-445.2002","article-title":"Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load.","volume":"40","author":"Kimura","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"21713","DOI":"10.1074\/jbc.m501564200","article-title":"Hepatitis B virus DNA-negative dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain.","volume":"280","author":"Kimura","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B88","doi-asserted-by":"crossref","first-page":"E4244","DOI":"10.1073\/pnas.1409986111","article-title":"Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses.","volume":"111","author":"K\u00f6niger","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B89","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1038\/sj.onc.1209559","article-title":"Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis.","volume":"25","author":"Kremsdorf","year":"2006","journal-title":"Oncogene"},{"key":"B90","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jhep.2012.10.025","article-title":"Effect of nucleos (t) ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis.","volume":"58","author":"Kumada","year":"2013","journal-title":"J. Hepatol."},{"key":"B91","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00680-17","article-title":"Hepatitis B virus capsid assembly modulators, but not nucleoside analogs, inhibit the production of extracellular pregenomic RNA and spliced RNA variants.","volume":"61","author":"Lam","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2008.05.007","article-title":"Hepatitis B pregenomic RNA splicing\u2014the products, the regulatory mechanisms and its biological significance.","volume":"136","author":"Lee","year":"2008","journal-title":"Virus Res."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01236-9","article-title":"Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos (t) ide analogue-induced hepatitis B e antigen Seroclearance.","volume":"20","author":"Lee","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.1128\/jvi.78.14.7455-7464.2004","article-title":"Three novel cis-acting elements required for efficient plus-strand DNA synthesis of the hepatitis B virus genome.","volume":"78","author":"Lee","year":"2004","journal-title":"J. Virol."},{"key":"B95","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-induced hepatocellular carcinoma.","volume":"64","author":"Levrero","year":"2016","journal-title":"J. Hepatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/hep.31230","article-title":"Cell-Free Virus-Host Chimera DNA From Hepatitis B virus integration sites as a circulating biomarker of hepatocellular cancer.","volume":"72","author":"Li","year":"2020","journal-title":"Hepatology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s0009-8981(01)00644-1","article-title":"AFP-L3: a new generation of tumor marker for hepatocellular carcinoma.","volume":"313","author":"Li","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"B98","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000324197","article-title":"High hepatitis B virus DNA level in serum before liver transplantation increases the risk of hepatocellular carcinoma recurrence.","volume":"84","author":"Li","year":"2011","journal-title":"Digestion"},{"key":"B99","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/1389202919666181002144336","article-title":"Profile of HBV integration in the plasma DNA of hepatocellular carcinoma patients.","volume":"20","author":"Li","year":"2019","journal-title":"Curr. Genomics"},{"key":"B100","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jhep.2015.09.013","article-title":"Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122.","volume":"64","author":"Liang","year":"2016","journal-title":"J. Hepatol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4103\/2319-4170.143485","article-title":"Comparison of the elecsys HBsAg II assay and the architect assay for quantification of hepatitis B surface antigen in chronic hepatitis B patients.","volume":"38","author":"Liao","year":"2015","journal-title":"Biomed. J."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/j.1440-1746.2006.04515.x","article-title":"Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma.","volume":"22","author":"Lin","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jhep.2006.08.021","article-title":"Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.","volume":"46","author":"Lin","year":"2007","journal-title":"J. Hepatol."},{"key":"B104","first-page":"11","article-title":"Structural and functional analysis of 2.2 kb spliced variant of hepatitis B virus genomes isolated from liver tissues from hepatocellular carcinoma patients.","volume":"16","author":"Lin","year":"2002","journal-title":"Chin. J. Exp. Clin. Virol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jviromet.2017.09.015","article-title":"Development of a digital droplet PCR assay to measure HBV DNA in patients receiving long-term TDF treatment.","volume":"249","author":"Liu","year":"2017","journal-title":"J. Virol. Methods"},{"key":"B106","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s11684-017-0590-z","article-title":"Potential use of serum HBV RNA in antiviral therapy for chronic hepatitis B in the era of nucleos (t) ide analogs.","volume":"11","author":"Lu","year":"2017","journal-title":"Front. Med."},{"key":"B107","doi-asserted-by":"crossref","DOI":"10.1177\/1533033819846632","article-title":"A logistic regression model for noninvasive prediction of AFP-negative hepatocellular carcinoma.","volume":"18","author":"Luo","year":"2019","journal-title":"Technol. Cancer Res. Treat."},{"key":"B108","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1158\/1078-0432.ccr-07-5082","article-title":"COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis.","volume":"14","author":"Ma","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/apt.14376","article-title":"Review article: hepatitis B core-related antigen (HB crAg): an emerging marker for chronic hepatitis B virus infection.","volume":"47","author":"Mak","year":"2018","journal-title":"Aliment. Pharmacol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1053\/j.gastro.2004.06.021","article-title":"Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years.","volume":"127","author":"Manno","year":"2004","journal-title":"Gastroenterology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2018.12.003","article-title":"C-terminal truncated HBx protein activates caveolin-1\/LRP6\/\u03b2-catenin\/FRMD5 axis in promoting hepatocarcinogenesis.","volume":"444","author":"Mao","year":"2019","journal-title":"Cancer Lett."},{"key":"B112","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","article-title":"\u03b1-fetoprotein, des-\u03b3 carboxyprothrombin, and lectin-bound \u03b1-fetoprotein in early hepatocellular carcinoma.","volume":"137","author":"Marrero","year":"2009","journal-title":"Gastroenterology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases.","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"B114","doi-asserted-by":"publisher","first-page":"8396","DOI":"10.1128\/jvi.00700-09","article-title":"Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection.","volume":"83","author":"Mason","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"B115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cld.2015.01.001","article-title":"Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.","volume":"19","author":"McGlynn","year":"2015","journal-title":"Clin. Liver Dis."},{"key":"B116","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1074\/jbc.m207634200","article-title":"Proteolytic processing of the hepatitis B virus e antigen precursor: cleavage at two furin consensus sequences.","volume":"278","author":"Messageot","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B117","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1084\/jem.188.2.341","article-title":"Immune pathogenesis of hepatocellular carcinoma.","volume":"188","author":"Nakamoto","year":"1998","journal-title":"J. Exp. Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1111\/j.1572-0241.2006.00681.x","article-title":"Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.","volume":"101","author":"Nakamura","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"24005","DOI":"10.18632\/oncotarget.8209","article-title":"C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.","volume":"7","author":"Ng","year":"2016","journal-title":"Oncotarget"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"B121","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/jvh.13260","article-title":"Insights for clinical diagnostic indicators of virus and host in chronic hepatitis B infection.","volume":"27","author":"Ou","year":"2020","journal-title":"J. Viral Hepat."},{"key":"B122","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12029-017-9959-0","article-title":"Global epidemiology of hepatocellular carcinoma (HCC epidemiology).","volume":"48","author":"Ozakyol","year":"2017","journal-title":"J. Gastrointest. Cancer"},{"key":"B123","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy.","volume":"62","author":"Papatheodoridis","year":"2015","journal-title":"J. Hepatol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.virusres.2008.05.005","article-title":"Modulation of hepatitis B virus replication by expression of polymerase-surface fusion protein through splicing: implications for viral persistence.","volume":"136","author":"Park","year":"2008","journal-title":"Virus Res."},{"key":"B125","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1038\/sj.onc.1206492","article-title":"Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene.","volume":"22","author":"Paterlini-Brechot","year":"2003","journal-title":"Oncogene Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1477-2574.2012.00465.x","article-title":"Does transient elastography (FibroScan\u00ae) have a role in decision making in hepatocellular carcinoma?","volume":"14","author":"Pesce","year":"2012","journal-title":"HPB"},{"key":"B127","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jhep.2020.08.039","article-title":"Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B.","volume":"74","author":"Pfefferkorn","year":"2021","journal-title":"J. Hepatol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/apt.12370","article-title":"Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography\u2013a randomised study.","volume":"38","author":"Pocha","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B129","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-018-0994-7","article-title":"High serum levels of pregenomic RNA reflect frequently failing reverse transcription in hepatitis B virus particles.","volume":"15","author":"Prakash","year":"2018","journal-title":"Virol J."},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005893","article-title":"DNA polymerase \u03ba is a key cellular factor for the formation of covalently closed circular DNA of hepatitis B virus.","volume":"12","author":"Qi","year":"2016","journal-title":"PLoS Pathog."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/liv.13142","article-title":"Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis.","volume":"36","author":"Raffetti","year":"2016","journal-title":"Liver Int."},{"key":"B132","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41575-020-0296-6","article-title":"The evolution and clinical impact of hepatitis B virus genome diversity.","volume":"17","author":"Revill","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/hep.510280431","article-title":"Ultrastructural analysis of hepatitis B virus in HepG2-transfected cells with special emphasis on subviral filament morphogenesis.","volume":"28","author":"Roingeard","year":"1998","journal-title":"Hepatology"},{"key":"B134","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1046\/j.1365-2893.2003.00437.x","article-title":"Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment.","volume":"10","author":"Rokuhara","year":"2003","journal-title":"J. Viral Hepat."},{"key":"B135","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.virol.2017.05.017","article-title":"Hepatitis B surface antigen on subviral particles reduces the neutralizing effect of anti-HBs antibodies on hepatitis B viral particles in vitro.","volume":"509","author":"Rydell","year":"2017","journal-title":"Virology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1423-0410.2001.00003.x","article-title":"An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques.","volume":"80","author":"Saldanha","year":"2001","journal-title":"Vox Sang."},{"key":"B137","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1136\/gut.24.7.618","article-title":"Hepatitis B virus DNA in children\u2019s liver diseases: detection by blot hybridisation in liver and serum.","volume":"24","author":"Scotto","year":"1983","journal-title":"Gut Pathog."},{"key":"B138","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2036.2009.04014.x","article-title":"Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.","volume":"30","author":"Singal","year":"2009","journal-title":"Aliment. Pharmacol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1245\/s10434-014-3621-x","article-title":"HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.","volume":"21","author":"Sohn","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/jci8098","article-title":"In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA.","volume":"105","author":"Soussan","year":"2000","journal-title":"J. Clin. Invest."},{"key":"B141","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1086\/589623","article-title":"Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease.","volume":"198","author":"Soussan","year":"2008","journal-title":"J. Infect. Dis."},{"key":"B142","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/s0168-8278(02)00422-1","article-title":"The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis.","volume":"38","author":"Soussan","year":"2003","journal-title":"J. Hepatol."},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066457","article-title":"The influence of hepatitis B viral load and pre-S deletion mutations on post-operative recurrence of hepatocellular carcinoma and the tertiary preventive effects by anti-viral therapy.","volume":"8","author":"Su","year":"2013","journal-title":"PLoS One"},{"key":"B144","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1128\/jvi.63.9.4011-4018.1989","article-title":"Hepatitis B virus transcript produced by RNA splicing.","volume":"63","author":"Su","year":"1989","journal-title":"J. Virol."},{"key":"B145","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.","volume":"44","author":"Sung","year":"2012","journal-title":"Nat. Genet."},{"key":"B146","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/hepr.13277","article-title":"Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinoma.","volume":"49","author":"Suzuki","year":"2019","journal-title":"Hepatol. Res."},{"key":"B147","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/hep.25979","article-title":"C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun\/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma.","volume":"57","author":"Sze","year":"2013","journal-title":"Hepatol. Int."},{"key":"B148","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jhep.2016.03.013","article-title":"HBcrAg predicts hepatocellular carcinoma development: an analysis using time-dependent receiver operating characteristics.","volume":"65","author":"Tada","year":"2016","journal-title":"J. Hepatol."},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242748","article-title":"Hepatitis B virus pre-S2 deletion (nucleotide 1 to 54) in plasma predicts recurrence of hepatocellular carcinoma after curative surgical resection.","volume":"15","author":"Teng","year":"","journal-title":"PLoS One"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3390\/v12080796","article-title":"Next-generation sequencing-based quantitative detection of hepatitis B virus pre-S mutants in plasma predicts hepatocellular carcinoma recurrence.","volume":"12","author":"Teng","year":"","journal-title":"Viruses"},{"key":"B151","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1128\/jvi.65.10.5539-5543.1991","article-title":"Defective hepatitis B virus particles are generated by packaging and reverse transcription of spliced viral RNAs in vivo.","volume":"65","author":"Terre","year":"1991","journal-title":"J. Virol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jhep.2018.11.030","article-title":"Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.","volume":"70","author":"Testoni","year":"2019","journal-title":"J. Hepatol."},{"key":"B153","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jhep.2016.01.027","article-title":"Overview of hepatitis B viral replication and genetic variability.","volume":"64","author":"Tong","year":"2016","journal-title":"J. Hepatol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.aohep.2019.02.002","article-title":"No expression of HBV-human chimeric fusion transcript (HBx-LINE1) among Vietnamese patients with HBV-associated hepatocellular carcinoma.","volume":"18","author":"Trung","year":"2019","journal-title":"Ann. Hepatol."},{"key":"B155","first-page":"1518","article-title":"High Level of Hepatitis B Core\u2013Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.","volume":"157","author":"Tseng","year":"2019","journal-title":"Gastroenterol. Hepatol."},{"key":"B156","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2012.02.007","article-title":"High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.","volume":"142","author":"Tseng","year":"2012","journal-title":"Gastroenterology"},{"key":"B157","first-page":"7803","article-title":"Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.","volume":"61","author":"Tu","year":"2001","journal-title":"Cancer Res."},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3390\/v12050515","article-title":"The lived experience of chronic hepatitis B: a broader view of its impacts and why we need a cure.","volume":"12","author":"Tu","year":"","journal-title":"Viruses"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3390\/v9040075","article-title":"HBV DNA integration: molecular mechanisms and clinical implications.","volume":"9","author":"Tu","year":"2017","journal-title":"Viruses"},{"key":"B160","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coviro.2018.04.004","article-title":"Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections.","volume":"30","author":"Tu","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"B161","article-title":"Hepatitis B virus (HBV) DNA integration is not driven by viral proteins.","volume":"57","author":"Tu","year":"2019","journal-title":"Z. Gastroenterol."},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104865","article-title":"A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc) DNA formation and maintenance.","volume":"181","author":"Tu","year":"","journal-title":"Antiviral Res."},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100195","article-title":"De novo synthesis of hepatitis B virus nucleocapsids is dispensable for the maintenance and transcriptional regulation of cccDNA.","volume":"3","author":"Tu","year":"2021","journal-title":"JHEP Rep."},{"key":"B164","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/hep.27381","article-title":"Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors.","volume":"61","author":"van B\u00f6mmel","year":"2015","journal-title":"Hepatology"},{"key":"B165","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/hep.29872","article-title":"Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatment.","volume":"68","author":"van Campenhout","year":"2018","journal-title":"Hepatology"},{"key":"B166","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3350\/cmh.2016.0045","article-title":"The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy.","volume":"22","author":"Varbobitis","year":"2016","journal-title":"Clin. Mol. Hepatol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-virology-110615-042238","article-title":"The structural biology of hepatitis B virus: form and function.","volume":"3","author":"Venkatakrishnan","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"8822","DOI":"10.3748\/wjg.v19.i47.8822","article-title":"Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.","volume":"19","author":"Vlachogiannakos","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/cbm-2007-3202","article-title":"Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3 1.","volume":"3","author":"Volk","year":"2007","journal-title":"Cancer Biomark."},{"key":"B170","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1349-7006.2006.00235.x","article-title":"Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis.","volume":"97","author":"Wang","year":"2006","journal-title":"Cancer Sci."},{"key":"B171","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/s0002-9440(10)63599-7","article-title":"Different types of ground glass hepatocytes in chronic Hepatitis B virus infection contain specific Pre-S Mutants that May induce endoplasmic reticulum stress.","volume":"163","author":"Wang","year":"2003","journal-title":"Am. J. Pathol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jhep.2016.10.034","article-title":"Reply to:\u201cSerum HBV pgRNA as a clinical marker for cccDNA activity\u201d: consistent loss of serum HBV RNA might predict the \u201cpara-functional cure\u201d of chronic hepatitis B.","volume":"66","author":"Wang","year":"2017","journal-title":"J. Hepatol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jhep.2016.05.029","article-title":"Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound.","volume":"65","author":"Wang","year":"2016","journal-title":"J. Hepatol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jhep.2017.08.021","article-title":"Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients.","volume":"68","author":"Wang","year":"2018","journal-title":"J. Hepatol."},{"key":"B175","article-title":"Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: a Meta-analysis.","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed Res. Int."},{"key":"B176","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/sj.onc.1206889","article-title":"Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis.","volume":"23","author":"Wang","year":"2004","journal-title":"Oncogene"},{"key":"B177","first-page":"4090","author":"Wang","year":"2019","journal-title":"Cell-Free Junctional DNA Fragment from Hepatitis B Virus Integration in HCC for Monitoring Postresection Recurrence and Clonality."},{"key":"B178","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.patbio.2010.03.005","article-title":"Molecular biology of the hepatitis B virus and role of the X gene.","volume":"58","author":"Wei","year":"2010","journal-title":"Pathol. Biol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/liv.13346","article-title":"Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA.","volume":"37","author":"Wong","year":"2017","journal-title":"Liver Int."},{"key":"B180","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cgh.2019.06.029","article-title":"Among patients with undetectable hepatitis B surface antigen and hepatocellular carcinoma, a high proportion has integration of HBV DNA into hepatocyte DNA and no cirrhosis.","volume":"18","author":"Wong","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan0241","article-title":"RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg.","volume":"9","author":"Wooddell","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B182","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jhep.2009.07.009","article-title":"Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.","volume":"51","author":"Wu","year":"2009","journal-title":"J. Hepatol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/jvh.13402","article-title":"Meta-analysis: association between hepatitis B virus preS mutation and hepatocellular carcinoma risk.","volume":"28","author":"Wungu","year":"2021","journal-title":"J. Viral Hepat."},{"key":"B184","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2893.2010.01346.x","article-title":"Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth.","volume":"18","author":"Xiangji","year":"2011","journal-title":"J. Viral Hepat."},{"key":"B185","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11684-010-0160-0","article-title":"Association of novel mutations and heplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma.","volume":"4","author":"Xie","year":"2010","journal-title":"Front. Med. China"},{"key":"B186","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bpg.2017.04.011","article-title":"Mechanism and prediction of HCC development in HBV infection.","volume":"31","author":"Xu","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1128\/jvi.03478-13","article-title":"Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.","volume":"88","author":"Yan","year":"2014","journal-title":"J. Virol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/hep.27722","article-title":"Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma.","volume":"61","author":"Yan","year":"2015","journal-title":"Hepatology"},{"key":"B189","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"B190","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jhep.2007.06.021","article-title":"Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver.","volume":"48","author":"Yang","year":"2008","journal-title":"J. Hepatol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cgh.2010.08.019","article-title":"Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma.","volume":"9","author":"Yang","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrgastro.2010.100","article-title":"Hepatocellular carcinoma: a global view.","volume":"7","author":"Yang","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"9710","DOI":"10.1128\/jvi.73.12.9710-9717.1999","article-title":"Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor.","volume":"73","author":"Yang","year":"1999","journal-title":"J. Virol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"8710","DOI":"10.1128\/jvi.72.11.8710-8717.1998","article-title":"Infection of ducklings with virus particles containing linear double-stranded duck hepatitis B virus DNA: illegitimate replication and reversion.","volume":"72","author":"Yang","year":"1998","journal-title":"J. Virol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jcv.2014.04.008","article-title":"Comparison of the Abbott RealTime HBV assay with the Roche Cobas AmpliPrep\/Cobas TaqMan HBV assay for HBV DNA detection and quantification.","volume":"60","author":"Yeh","year":"2014","journal-title":"J. Clin. Virol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/hep.29790","article-title":"Hepatitis B virus surface gene pre-S2 mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resection.","volume":"68","author":"Yen","year":"2018","journal-title":"Hepatology"},{"key":"B197","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jhep.2017.06.019","article-title":"Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.","volume":"67","author":"Yip","year":"2017","journal-title":"J. Hepatol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jhep.2018.10.014","article-title":"HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.","volume":"70","author":"Yip","year":"2019","journal-title":"J. Hepatol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/apt.15429","article-title":"The role of hepatitis B core-related antigen in predicting hepatitis B virus recurrence after liver transplantation.","volume":"50","author":"Yu","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B200","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00432-004-0552-0","article-title":"Randomized controlled trial of screening for hepatocellular carcinoma.","volume":"130","author":"Zhang","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000009377","article-title":"Hepatitis B surface antigen predicts recurrence after radiofrequency ablation in patients with low hepatitis B virus loads.","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine"},{"key":"B202","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1385\/1-59259-669-x:29","article-title":"Detection of HBV RNA in serum of patients.","volume":"95","author":"Zhang","year":"2004","journal-title":"Methods Mol. Med."},{"key":"B203","article-title":"Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.","volume":"7","author":"Zhao","year":"2016","journal-title":"Nat. Commun."},{"key":"B204","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/gutjnl-2014-308989","article-title":"Serum viral duplex-linear DNA proportion increases with the progression of liver disease in patients infected with HBV.","volume":"65","author":"Zhao","year":"2016","journal-title":"Gut"},{"key":"B205","first-page":"756","article-title":"Level of hepatitis B surface antigen might serve as a new marker to predict hepatocellular carcinoma recurrence following curative resection in patients with low viral load.","volume":"5","author":"Zhou","year":"2015","journal-title":"Am. J. Cancer Res."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.665201\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T09:42:18Z","timestamp":1623663738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.665201\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":205,"alternative-id":["10.3389\/fmicb.2021.665201"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.665201","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,14]]},"article-number":"665201"}}